Prevention of myocardial reinfarction. Recommendations based on results of drug trials
Flaker, G.C.; Singh, V.N.
Postgraduate Medicine 94(6): 94
1993
ISSN/ISBN: 0032-5481 PMID: 7901845 Document Number: 409941
Therapy after acute myocardial infarction offers the prospect of increased survival in carefully selected patients. Current recommendations favor the use of beta blockers and antiplatelet agents, but some positive effects have been seen with use of anticoagulants, angiotensin-converting enzyme inhibitors, and calcium channel blockers. Further studies are needed to evaluate these drug classes in reinfarction prophylaxis and to define differences among the agents in each class.
Document emailed within 1 workday
Related Documents
Burkart, F. 1985: Prevention of myocardial infarct and of reinfarction Therapeutische Umschau. Revue Therapeutique 42(8): 511-520Mazza, F.; Messore, T.; Contiello, V.; Ciappa, G.; Caropreso, M.R.; Petrillo, T.; Ucciero, R. 1985: Myocardial reinfarction. Considerations on secondary prevention Minerva Cardioangiologica 33(6): 325-328
Inglese, L.; Fantoni, C. 2010: ST-elevation myocardial infarction: reperfusion strategy based on the results from large clinical trials Giornale Italiano di Cardiologia 11(10 Suppl 1: 57s-60s
Piwowar-Manning, E.; Fiamma, A.; Laeyendecker, O.; Kulich, M.; Donnell, D.; Szekeres, G.; Robins-Morris, L.; Mullis, C.E.; Vallari, A.; Hackett, J.; Mastro, T.D.; Gray, G.; Richter, L.; Alexandre, M.W.; Chariyalertsak, S.; Chingono, A.; Sweat, M.; Coates, T.; Eshleman, S.H. 2011: HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043) Bmc Infectious Diseases 11: 251
Bellamy, N.; Carette, S.; Ford, P.M.; Kean, W.F.; le Riche, N.G.; Lussier, A.; Wells, G.A.; Campbell, J. 1992: Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise Journal of Rheumatology 19(3): 451-457
Veldhuyzen van Zanten, S.J.; Cleary, C.; Talley, N.J.; Peterson, T.C.; Nyrén, O.; Bradley, L.A.; Verlinden, M.; Tytgat, G.N. 1996: Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials American Journal of Gastroenterology 91(4): 660-673
Leickert, K.H. 1982: Coumarin derivatives in the prevention of reinfarction Die Medizinische Welt 33(50): 1832-1833
Bull, S.; Pratte, K.; Whitesell, N.; Rietmeijer, C.; McFarlane, M. 2009: Effects of an Internet-based intervention for HIV prevention: the Youthnet trials Aids and Behavior 13(3): 474-487
Njølstad, I.; Løchen, M.-L. 2002: Are results of large clinical drug trials valid for both men and women? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 122(12): 1210-1212
Wilhelmsen, L. 1988: ISIS-2--a study of patients with myocardial infarction. a combination of streptokinase and acetylsalicylic acid diminishes mortality risk, reinfarction and stroke Lakartidningen 85(35): 2759-2764
Colditz, G.A. 1996: Selenium and cancer prevention. Promising results indicate further trials required JAMA 276(24): 1984-1985
Decorde, P. 1984: Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration Pharmatherapeutica 3(8): 515-525
Takano, A.; Miyamoto, Y.; Kawakami, N.; Matsumoto, T. 2016: The potential of e-Health for treatment and prevention for drug dependence process of development and revision of web-based relapse prevention program "e-SMARPP" Nihon Arukoru Yakubutsu Igakkai Zasshi 51(6): 382-392
MacQueen, K.M.; Tolley, E.E.; Owen, D.H.; Amico, K.Rivet.; Morrow, K.M.; Moench, T.; Friend, D.R.; Friedland, B. 2014: An interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal rings Journal of the International Aids Society 17(3 Suppl. 2): 19158
Cowan, F.M.; Langhaug, L.F.; Mashungupa, G.P.; Nyamurera, T.; Hargrove, J.; Jaffar, S.; Peeling, R.W.; Brown, D.W.G.; Power, R.; Johnson, A.M.; Stephenson, J.M.; Bassett, M.T.; Hayes, R.J. 2002: School based HIV prevention in Zimbabwe: feasibility and acceptability of evaluation trials using biological outcomes Aids 16(12): 1673-1678
Schubert, W. 1972: Influence of long-term anticoagulant treatment on reinfarction, mortality and rehabilitation of patients with myocardial infarct. 4-year-observation ambulatory surveillance of infarction Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 27(7): 307-311
MacMahon, S.; Collins, R.; Peto, R.; Koster, R.W.; Yusuf, S. 1988: Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials JAMA 260(13): 1910-1916
Sidorenko, G.N.; Zoldakova, Z.I.; Krasovskij, G.N. 1989: Methodologic principles for the prognosis of chronic toxicity of substances based on results of short-term trials Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 35(3): 133-136
Essack, Z.; Koen, J.; Slack, C.; Lindegger, G.; Newman, P.A. 2012: Civil society perspectives on negative biomedical HIV prevention trial results and implications for future trials AIDS care 24(10): 1249-1254
Beermann, Börn. 2006: Reply concerning the new Medical Products Agency's guidelines for primary prevention of cardiovascular diseases. Issuing recommendations based on available evidence basis an ethical duty Lakartidningen 103(47): 3731-3732